neobookRx

Rhinosinusitis, Acute Bacterial (ABRS)

Description Diagnostic criteria General and supportive measures Medicine treatment ICD-10 code: J01 DESCRIPTION Inflammation or infection of one or more of the sinuses that occurs most often after a viral infection or with allergic rhinitis. DIAGNOSTIC CRITERIA Child with an acute upper respiratory tract infection presenting with: persistent illness (nasal discharge, facial pain/pressure, or dayt

Description

Diagnostic criteria

General and supportive measures

Medicine treatment


ICD-10 code: J01

DESCRIPTION

Inflammation or infection of one or more of the sinuses that occurs most often after a viral infection or with allergic rhinitis.

DIAGNOSTIC CRITERIA

Child with an acute upper respiratory tract infection presenting with:

  • persistent illness (nasal discharge, facial pain/pressure, or daytime cough lasting more than 10 days without improvement), a worsening course (worsening or new onset of nasal discharge, daytime cough, or pain/fever after initial improvement),

OR

  • severe onset (concurrent fever [temperature ≥ 39°C], pain and purulent nasal discharge for at least 3 consecutive days).

GENERAL AND SUPPORTIVE MEASURES

  • Steam inhalation to liquefy and remove secretions blocking the nose.

MEDICINE TREATMENT

For infection:

  • Amoxicillin, oral, 45 mg/kg/dose 12 hourly for 10 days.

Maximum dose: 1.5 g 12 hourly.

Note: For poor response to amoxicillin therapy, or in patients who have received amoxicillin in the last 30 days:

  • Amoxicillin/clavulanic acid, oral, 45 mg/kg/dose of amoxicillin component, 12 hourly for 5–10 days (amoxicillin/clavulanic acid in a ratio of 14:1).
    • Maximum dose of amoxicillin component: 1.5 g 12 hourly.

LoE III1,4

For pain and fever:

If allergic rhinitis is suspected, See: Rhinitis, Allergic/ Allergic Rhinosinusitis.


Standard Treatment Guidelines and Essential Medicines List for South Africa, Hospital Level, Paediatrics, 2023 Edition

Chapter 17: Ear Nose & Throat, 17.11 Rhinosinusitis, Acute Bacterial (ABRs)

Drugs mentioned

NeoHealth® ID 23770 · updated 5/13/2023